The MBS will fund genetic testing of women with hereditary mutations predisposing them to breast and ovarian cancers from 1 November. MBS funding for a seven-gene panel including BRCA 1 and 2 will also extend to family members of clinically affected women, according to a spokesperson from the Royal College of Pathologists of Australasia (RCPA). ...
Go ahead for funding of genetic tests for women
By Mardi Chapman
12 Oct 2017